Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals are medications used to treat infections caused by retroviruses. This is a group of RNA viruses that includes human immunodeficiency virus, or HIV, which can cause acquired immunodeficiency syndrome, or AIDS. Now, antiretrovirals include different classes of medications, among which some of the most commonly used are protease inhibitors.
Okay, so protease inhibitors, or PIs for short, are a class of antiretroviral medications with a characteristic suffix “-navir” in their drug names. Important protease inhibitors include indinavir, nelfinavir, saquinavir, atazanavir, fosamprenavir, tipranavir, darunavir, ritonavir, and a combination of ritonavir/lopinavir. All these medications are taken orally.
Once administered, protease inhibitors work by binding and inhibiting the viral enzyme HIV protease, which plays a major role in maturation of newly replicated viruses. The result is the formation of immature viruses, which are unable to continue infecting host cells.
Now common side effects associated with most protease inhibitors are fatigue, headache, and gastrointestinal side effects, such as diarrhea, nausea, and vomiting. Protease inhibitors can also cause hypersensitivity reactions, such as skin rashes, Stevens-Johnson syndrome, toxic epidermal necrolysis, and sometimes anaphylaxis.
They can also cause metabolic issues, such as insulin resistance, hyperglycemia, as well as hyperlipidemia, and hepatotoxicity. Some protease inhibitors may also lead to cushingoid fat redistribution, which typically involves peripheral wasting, along with truncal obesity, and the development of a fat pad on the base of the neck.
Clients taking protease inhibitors may also develop serious side effects, such as hemorrhage, especially in clients with a preexisting bleeding disorder called hemophilia; as well as an excessive inflammatory response called immune reconstitution syndrome, that can also cause flare-ups of a previously known infection like tuberculosis.
| ANTIRETROVIRALS: PROTEASE INHIBITORS | ||
| DRUG NAME | indinavir (Crixivan); nelfinavir (Viracept); atazanavir (Reyataz); fosamprenavir (Lexiva); tipranavir (Aptivus); darunavir (Prezista); saquinavir (Invirase), ritonavir (Norvir); ritonavir / lopinavir (Kaletra) *High Alert Medications* | |
| CLASS | Protease inhibitors (PIs) | |
| MECHANISM of ACTION | Inhibit HIV protease, preventing viral maturation | |
| INDICATIONS | Treatment of HIV infection in combination with other antiretrovirals | |
| ROUTE(S) of ADMINISTRATION | PO | |
| SIDE EFFECTS |
| |
| CONTRAINDICATIONS & CAUTIONS |
Drug interactions:
| |
| NURSING CONSIDERATIONS for ANTIRETROVIRALS: PROTEASE INHIBITORS | ||
| ASSESSMENT & MONITORING | Assessment
Monitoring
| |
| CLIENT EDUCATION |
| |
No notes for this video yet
Try adding a note below